Scientific deep-dive
Cellulitis, Obesity and Lymphedema: Risk Factors, Recurrence and What Prevents It
Cellulitis symptoms and why it keeps coming back. Evidence on obesity and lymphedema as leading risk factors for leg cellulitis, how compression and preventive antibiotics cut recurrence, what weight loss can and cannot change, and the limited GLP-1 data.
Cellulitis is a bacterial infection of the deeper layers of the skin and the fat beneath it. It shows up as spreading redness, warmth, tenderness and swelling, most often on one lower leg, and it is extremely common: an estimated 14.5 million cases a year in the United States [1]. It also tends to come back, in as many as 29% of cases [2]. The strongest risk factors are local: broken skin, a previous episode, and chronic swelling of the leg from lymphedema or edema [4]. Obesity is a consistent, smaller risk factor, and genetic studies suggest it is a cause rather than a bystander [8]. This review covers the symptoms, the risk factors, what actually prevents another episode, and what weight loss and GLP-1 drugs can and cannot be expected to change.
About this article
This is an evidence review, not a treatment guide. Cellulitis needs prompt medical assessment and usually antibiotics. The risk-factor findings come from observational and genetic studies; prevention findings come from randomized trials. No trial has tested weight loss or a GLP-1 drug as a way to prevent cellulitis, and we say so where it matters.
The honest summary
- Local problems drive most leg cellulitis. A previous episode, wounds, leg ulcers and lymphedema or chronic leg swelling carried the highest odds in a meta-analysis; obesity raised the odds about 2.4-fold [4].
- Obesity looks causal. In a 2026 genetic study, each 5-point rise in BMI nearly doubled the odds of hospital admission for a bacterial skin infection [8].
- Recurrence is the real burden. Among people with two or more past episodes, 37% on placebo had another within a year [14].
- Compression stockings prevent repeat episodes in swollen legs. In a randomized trial, recurrence fell from 40% to 15% [16], and the benefit held at 18 months [17].
- Weight loss is reasonable risk reduction, not a proven treatment. No trial has tested it, and lymphedema caused by severe obesity does not always reverse after major weight loss [21][13].
- GLP-1 data are thin. One database study linked GLP-1 use to fewer soft-tissue infections in people with obesity and vein disease; it cannot prove cause [19].
Cellulitis symptoms, and what it is often confused with
Cellulitis presents with expanding redness, warmth, tenderness and swelling of the skin [1]. It usually affects one leg; a rash on both legs at once is rarely cellulitis and points toward other causes such as venous stasis dermatitis [2]. In most cases no bacteria can be grown from the skin, and when an organism is found it is usually a streptococcus or Staphylococcus aureus [1].
There is no test that confirms cellulitis, so diagnosis rests on the history and examination, and mistakes are common [1]. In one US hospital, 30.5% of patients admitted from the emergency department with leg cellulitis turned out to have something else, and most of those received antibiotics they did not need [3]. The usual mimics include stasis dermatitis from chronic venous disease and a deep vein thrombosis, which clinicians are advised to consider before settling on cellulitis [2]. A blood clot can also cause a red, swollen, painful calf; see DVT and blood clots with obesity.
When to get same-day care
A red, hot, painful and swollen area of skin that is spreading, especially with fever or chills, needs prompt medical assessment. So does sudden swelling of one leg with calf pain, which can be a blood clot. Do not wait to see whether either settles on its own.
Who gets cellulitis in the legs?
A 2017 meta-analysis of six case-control studies ranked the risk factors for leg cellulitis that is not caused by a pus-filled abscess [4]. A previous episode carried the highest odds by far, followed by a wound, a leg ulcer, lymphedema or chronic leg edema, scratched or broken skin from conditions such as eczema, athlete's foot (tinea pedis) and a BMI over 30. Diabetes, smoking and alcohol were not associated with cellulitis in that analysis, and the authors concluded that local risk factors matter more than whole-body ones.
Magnitude comparison
Odds of leg cellulitis by risk factor, from a meta-analysis of case-control studies. 1.0 means no difference.[4]
- Previous cellulitis40.3 OR
- Wound19.1 OR
- Current leg ulcer13.7 OR
- Lymphedema or chronic leg edema6.8 OR
- Excoriating skin disease4.4 OR
- Tinea pedis (athlete’s foot)3.2 OR
- BMI over 302.4 OR
Lymphedema and leg swelling
Swelling caused by poor lymph drainage is one of the strongest risk factors. In the French study that first quantified it, lymphedema was linked to 71 times the odds of leg erysipelas, a superficial form of cellulitis, although the estimate was very imprecise [5]. In a referral center for lymphedema, 37.6% of 1,846 patients had had at least one episode of cellulitis and 23.3% had had repeated episodes [11]. A large Australian population study of first severe episodes also found more lymphedema and varicose veins among people with cellulitis [7]. Leg swelling from chronic venous disease belongs to the same picture; see varicose veins, venous insufficiency and weight. For lymphedema itself, including how it is treated, see lymphedema and weight loss.
Obesity
The link between obesity and cellulitis is consistent across study designs. A 2024 meta-analysis of nine case-control studies with 68,148 participants found 2.67 times the odds of cellulitis with obesity; being overweight but not obese was not clearly linked [6]. In the Australian population study of 29,062 matched pairs, obesity carried about twice the odds of a first severe episode [7].
Observational links can be explained by other factors, so genetic studies are useful here. A 2026 Mendelian randomization study using UK Biobank and FinnGen found that genetically higher BMI raised the odds of bacterial skin infection: by 37% per 5 kg/m² for infections treated in primary care and by 93% for hospital admissions [8]. An earlier genetic study also found BMI raised the risk of skin and soft-tissue infections overall, although its specific link to cellulitis disappeared after accounting for type 2 diabetes and peripheral vascular disease [9]. That suggests part of the effect runs through those conditions.
Entry points: toe webs and broken skin
Bacteria usually need a way in. In the French case-control study, cracked skin between the toes accounted for an estimated 61% of the population's risk of leg erysipelas [5]. In an Icelandic study, carrying S. aureus or streptococci in the toe webs was strongly linked to cellulitis [18]. Skin-fold rashes, which are more common with higher body weight, are another route for skin breakdown; see intertrigo and skin-fold rashes.
Recurrent cellulitis: who is most at risk
Once cellulitis has happened, it often returns. In a Minnesota population cohort, 16.7% had a recurrence within two years, and the risk was highest when the infection involved the shin, when there was a past cancer, or when the same leg had dermatitis [10]. Recurrence has been reported in as many as 29% of cases, with lymphedema, leg edema and cancer among the main risk factors [2]. In a Finnish study, obesity was significantly more common among patients who had had cellulitis before than among those with a first episode [20].
Severe obesity and lymphedema overlap. Among 98 patients assessed at a Boston lymphedema center, the chance of abnormal leg lymph drainage rose with BMI: 0% below a BMI of 40, 17% at 40 to 49, 63% at 50 to 59 and 86% at 60 to 69 [12]. Among those with abnormal drainage, 65% had a history of cellulitis, compared with 15% of people with obesity and normal drainage. Severe obesity can therefore raise cellulitis risk both directly and by causing lymphedema, which is itself one of the strongest risk factors.
What prevents another episode
Compression for swollen legs
For people with chronic leg swelling and repeated cellulitis, compression has the best trial evidence among the non-drug options. In an Australian randomized trial, 84 people received either compression garments plus education or education alone [16]. Cellulitis returned in 15% of the compression group versus 40% of the control group (hazard ratio 0.23), and the trial was stopped early because the difference was clear. In extended follow-up to 18 months, recurrence was 20% versus 47%, hospital admissions for cellulitis were halved, and 85% of participants still wore their garments at least four days a week [17]. The trial was small, single-center and not blinded.
Low-dose antibiotics
For people who have had two or more episodes, a year of low-dose penicillin reduces recurrence while it is being taken. In the PATCH I trial of 274 patients, 22% had a recurrence on penicillin versus 37% on placebo, so about five people needed treatment to prevent one episode [14]. The protection faded after the tablets stopped: in the follow-up period, 27% of both groups had a recurrence. A Cochrane review of five antibiotic trials found prophylaxis cut the risk of recurrence by 69% during treatment, with mostly minor side effects, but noted that none of the trials tested lymphedema reduction or skin care [15].
| Approach | Evidence | Result |
|---|---|---|
| Compression garments (chronic leg swelling) | Randomized trial, 84 people | Recurrence 15% vs 40% |
| Compression, extended follow-up | Same trial, 90 people, 18 months | Recurrence 20% vs 47% |
| Penicillin 250 mg twice daily for 12 months | Randomized trial, 274 people | Recurrence 22% vs 37% while taking it |
| Antibiotic prophylaxis (pooled) | Cochrane review, 5 trials | 69% lower risk during treatment |
| Treating toe-web skin breaks and athlete’s foot | Case-control studies only | Strong link to risk; not tested in a trial |
| Weight loss | No trial | Untested as a prevention strategy |
Does losing weight help?
Weight loss addresses one of the risk factors, and the genetic evidence suggests a lower BMI should lower the risk of skin infections [8]. But no trial has tested weight loss as a way to prevent cellulitis, so the size of any benefit is unknown.
The lymphedema findings add a caution. In the Boston program, people whose BMI had fallen from above 60 to below 50 had mixed results on lymph imaging: four had normal drainage and three still had abnormal drainage [21]. In a single documented patient, BMI fell from 80 to 36 after sleeve gastrectomy, yet lymph drainage in the legs did not improve 18 months later [13]. The authors advised seeking weight loss before BMI reaches about 50, the level at which obesity-induced lymphedema begins to appear. Once lymphedema is established, compression and skin care remain the core of prevention regardless of weight change.
What is known about GLP-1 drugs and cellulitis
Very little. No randomized trial has looked at GLP-1 drugs and cellulitis. One 2026 database study followed people aged 40 and over with obesity and chronic venous insufficiency, matching 12,379 GLP-1 users with 12,379 non-users [19]. At one year, GLP-1 users had fewer soft-tissue infections (hazard ratio 0.61), along with fewer blood clots and leg ulcers.
That result needs caution. The study relied on diagnosis codes, the drugs were not assigned at random, and GLP-1 users also had a 9-percentage-point survival advantage at three years, a gap too large to credit to the drug alone and a sign that users may have been healthier to begin with [19]. For now, the realistic expectation is that a GLP-1 drug may help indirectly, by lowering weight and improving blood sugar, and that the proven prevention steps still apply. For skin healing on these drugs, see GLP-1 drugs and diabetic foot ulcers, and for leg changes during weight loss, see Ozempic feet and legs.
Practical steps
- Get spreading redness and swelling checked the same day, especially with fever [1].
- If both legs are red, ask about other causes. Cellulitis on both legs at once is rare [2].
- Check between your toes. Treat cracks and athlete's foot, which are common entry points [5][18].
- If your legs are chronically swollen, ask about compression garments. They cut recurrence in a randomized trial [16].
- After two or more episodes, ask whether preventive antibiotics fit your case [14][15].
- Treat weight loss as risk reduction. Higher BMI raises skin-infection risk [8], but losing weight has not been tested as a cellulitis treatment, and lymphedema may persist after it [13].
Frequently Asked Questions
References
- 1.Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA. 2016. PMID: 27434444.
- 2.Chambliss ML, Rumball A, Brown CM. Skin and Soft Tissue Infections. Am Fam Physician. 2026. PMID: 42202366.
- 3.Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis. JAMA Dermatol. 2017. PMID: 27806170.
- 4.Quirke M, Ayoub F, McCabe A, Boland F, Smith B, O'Sullivan R, et al. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol. 2017. PMID: 27864837.
- 5.Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999. PMID: 10364117.
- 6.Taira KG, Wang M, Guo W, Kam O, Kaufmann T. Association of Cellulitis With Obesity: Systematic Review and Meta-Analysis. JMIR Dermatol. 2024. PMID: 39163102.
- 7.Cannon J, Rajakaruna G, Dyer J, Carapetis J, Manning L. Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. Clin Microbiol Infect. 2018. PMID: 29427797.
- 8.Hopkins R, de Villiers E, Weedon MN, Shields BM, Dennis JM, McGovern AP, et al. Higher Body Mass Index Is a Causal Risk Factor for Skin Infections: A Mendelian Randomisation Study Using UK Biobank and FinnGen. Diabetes Obes Metab. 2026. PMID: 42010892.
- 9.Hu H, Mei J, Lin M, Wu X, Lin H, Chen G. The causal relationship between obesity and skin and soft tissue infections: A two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2022. PMID: 36568121.
- 10.McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007. PMID: 17420430.
- 11.Vignes S, Poizeau F, Dupuy A. Cellulitis risk factors for patients with primary or secondary lymphedema. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 33957278.
- 12.Greene AK, Sudduth CL. Lower extremity lymphatic function predicted by body mass index: a lymphoscintigraphic study of obesity and lipedema. Int J Obes (Lond). 2021. PMID: 32934317.
- 13.Greene AK, Grant FD, Maclellan RA. Obesity-induced Lymphedema Nonreversible following Massive Weight Loss. Plast Reconstr Surg Glob Open. 2015. PMID: 26180727.
- 14.Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013. PMID: 23635049.
- 15.Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017. PMID: 28631307.
- 16.Webb E, Neeman T, Bowden FJ, Gaida J, Mumford V, Bissett B. Compression Therapy to Prevent Recurrent Cellulitis of the Leg. N Engl J Med. 2020. PMID: 32786188.
- 17.Webb E, Neeman T, Bowden FJ, Gaida J, Mumford V, Bissett B. Sustained benefit of compression therapy for preventing recurrent leg cellulitis: extended follow-up of a randomised controlled trial. EClinicalMedicine. 2026. PMID: 42597865.
- 18.Björnsdóttir S, Gottfredsson M, Thórisdóttir AS, Gunnarsson GB, Ríkardsdóttir H, Kristjánsson M, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005. PMID: 16231251.
- 19.Micalo L, Archie M, Rowe VL, Adewale AP, Pham NV, Li A, et al. Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42323127.
- 20.Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010. PMID: 19694769.
- 21.Greene AK, Grant FD, Slavin SA, Maclellan RA. Obesity-induced lymphedema: clinical and lymphoscintigraphic features. Plast Reconstr Surg. 2015. PMID: 25724063.
Related research
Intertrigo and Skin Fold Rash: What Changes as Weight Comes Off
Chafing, thigh chafing and intertrigo: the rash where skin rubs on skin. How chafing differs from intertrigo, what prevents it, when it turns into an infection, and why losing weight usually helps, with an awkward middle phase.
9 min read
Lymphedema and Weight Loss: What the Evidence Shows
Does weight loss help lymphedema? Obesity raises the risk of arm lymphedema after breast cancer and, at extreme BMI, can cause leg lymphedema on its own. What weight-loss trials, bariatric surgery and early GLP-1 data show about limb volume.
9 min read
Compression Garments After Weight Loss: What They Do and Do Not Do
Compression garments get recommended after weight loss for medical and cosmetic reasons, and the evidence differs sharply between them. What is guideline-backed, what is post-surgical convention, and what no garment will do.
6 min read
Degenerative Disc Disease and Body Weight: What MRI Studies Show
Does body weight cause degenerative disc disease? MRI and genetic studies on BMI and lumbar disc degeneration, why scans often show it without pain, what happens to discs and back pain after major weight loss, and what is known about GLP-1 drugs.
10 min read
Diastasis Recti and Body Weight: Does Losing Weight Close the Gap?
What diastasis recti is, its symptoms, and how it differs after pregnancy and with abdominal weight, including in men. Evidence on whether weight loss or GLP-1 drugs close the gap, which exercises help, surgery and BMI, and the overlap with umbilical hernia.
10 min read
DVT and Blood Clots with Obesity: Estrogen, Surgery and What GLP-1 Data Show
Deep vein thrombosis and pulmonary embolism symptoms, how obesity raises clot risk and multiplies the risk from the pill and oral HRT, the surgical window, what weight loss changes, and the conflicting trial and real-world evidence on GLP-1 drugs and blood clots.
11 min read
Where to get GLP-1 safely: vetted online providers
Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
SkinnyRx
Mainstream telehealth GLP-1 access
Pricing Compare
Get started →Embody
Low flat-rate compounded GLP-1 pricing at every dose
Pricing Compare
Get started →YourEra
$99 first-month entry pricing on compounded GLP-1s
Pricing Compare
Get started →